Medical Product Substitution Fulfillment (Alternative Sourcing)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract pertains to the fulfillment of a therapeutically equivalent substitute for Adenosine Injection that has received FDA approval, to be supplied under authorized medical substitution protocols. The product must comply with all regulatory standards for packaging, labeling, and delivery, ensuring seamless integration into existing clinical supply chains. This agreement is structured as a subcontract under the Defense Logistics Agency, operating under the Department of Defense, with the North American Industry Classification System code 325412, indicating involvement in pharmaceutical and medicine manufacturing. The fulfillment is intended to support medical readiness and operational continuity by securing an approved alternative to Adenosine Injection, thereby mitigating potential supply disruptions while maintaining therapeutic fidelity and patient safety. The contract was posted on August 1, 2026, and is linked to a specific delivery and procurement record under the contract number SPE2DP26F8604.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
